A carregar...
Identification of a Potent Phosphoinositide 3‐Kinase Pan Inhibitor Displaying a Strategic Carboxylic Acid Group and Development of Its Prodrugs
Activation of the phosphoinositide 3‐kinase (PI3K) pathway is a key signaling event in cancer, inflammation, and other proliferative diseases. PI3K inhibitors are already approved for some specific clinical indications, but their systemic on‐target toxicity limits their larger use. In particular, wh...
Na minha lista:
Publicado no: | ChemMedChem |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
John Wiley and Sons Inc.
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5697638/ https://ncbi.nlm.nih.gov/pubmed/28857471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cmdc.201700340 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|